A new route to vaccines using PROTACs

Nat Biotechnol. 2022 Sep;40(9):1328-1329. doi: 10.1038/s41587-022-01406-y.

Authors

Brad Gilbertson¹, Kanta Subbarao^{2

3}

Affiliations

¹ Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Victoria, Australia.
² Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Victoria, Australia. kanta.subbarao@influenzacentre.org.
³ WHO Collaborating Centre for Reference and Research on Influenza at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. kanta.subbarao@influenzacentre.org.

PMID: 35869290
DOI: 10.1038/s41587-022-01406-y

No abstract available

Publication types

Comment

MeSH terms

Drug Discovery*
Intercellular Signaling Peptides and Proteins
Proteolysis
Vaccines*

Substances

Intercellular Signaling Peptides and Proteins
Vaccines
snake venom protein C activator